By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Addex Therapeutics 

12, Chemin Des Aulx
1228 Plan-les-Ouates
Geneva      Switzerland
Phone: 41-22-884-1555 Fax: 41-22-884-1556




Company News
Addex Therapeutics (ADXN.SW) ADX71441 Positive Results In Preclinical Model Of Nicotine Addiction 7/10/2014 6:06:33 AM
Addex Therapeutics (ADXN.SW) Shareholders Approve All Board Proposals At Annual General Meeting 6/30/2014 8:53:27 AM
Addex Therapeutics (ADXN.SW) Publishes Annual General Meeting Agenda 6/12/2014 2:05:54 PM
Addex Therapeutics (ADXN.SW)-Janssen Pharmaceutical Inc. Team's Depression Drug Fails In Phase 2a Trial 2/10/2014 7:32:27 AM
Addex Therapeutics (ADXN.SW) and National Institute on Drug Abuse (NIDA) Enter Collaboration to Advance ADX71441 & ADX88178 in Drug Abuse and Addiction 11/4/2013 9:39:09 AM
Addex Therapeutics (ADXN.SW) Licensee Completes Enrollment of 120 Patients in a Phase 2 Clinical Trial of ADX71149 for the Treatment of Anxious Depression 10/29/2013 9:30:12 AM
Addex Therapeutics (ADXN.SW) ADX71441 Dose Dependently Reduced PMP22 Expression Comparable to Baclofen in a Pre-Clinical Transgenic Model of Charcot-Marie-Tooth 1A Disease 10/3/2013 9:53:37 AM
Addex Therapeutics (ADXN.SW) First Half 2013 Financial Results 9/17/2013 9:28:17 AM
Chronic Treatment With Addex Therapeutics (ADXN.SW) Dipraglurant Rescues Impairment of Long-Term Synaptic Plasticity in a Validated Preclinical Model of Primary Generalized Torsion Dystonia 1 9/4/2013 11:56:58 AM
Addex Therapeutics (ADXN.SW) Raises $3.4 Million in a Private Placement to International Institutional Investors 8/9/2013 8:31:07 AM